This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignee: Disney Enterprises, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Maclean - Innovator in Diabetes Treatment Prediction
Introduction
David Maclean is an inventor based in Middletown, RI (US). He has made significant contributions to the field of diabetes treatment through his innovative patent applications. His work focuses on methods for predicting treatment responses in patients with Type II Diabetes Mellitus.
Latest Patent Applications
David Maclean's notable patent application is titled "Methods and Kits for Predicting Treatment Response in Type II Diabetes Mellitus Patients." This application presents a method for predicting how a Type II diabetes patient will respond to the medication rosiglitazone. The method involves analyzing biomarkers from a patient sample, which include interleukin-8, histidine, and citrate. These biomarkers are identified using classification analyses such as majority-vote based classifiers and support-vector machine (SVM) classifiers. Additionally, the application outlines a method for predicting treatment response to glyburide after eight weeks of therapy, utilizing biomarkers like sphingomyelin 23:1 and L-phenylalanine. The application also includes kits designed for these methods.
Conclusion
David Maclean's innovative approaches in predicting treatment responses for Type II diabetes patients highlight the potential for advancements in personalized medicine. His work aims to improve treatment outcomes for individuals suffering from this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile